Nuvation Bio, Inc. (NUVB)

6.07 +0.22 (+3.76%) USD  |  NYSE  |  Sep 21, 16:00
5.98 -0.09 (-1.48%) Pre-Market: 20:00
More

Nuvation Bio CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for NUVB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical CAPEX To Revenue (TTM) Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
December 31, 2025 --
September 30, 2025 --
June 30, 2025 --
Date Value
March 31, 2025 --
December 31, 2024 --
September 30, 2024 --
June 30, 2024 --

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade